Barely Significant
← all excerpts

Zinc Therapy in Mild Cognitive Impairment: Cognitive Stabilization in Pharmacodynamically Responsive Patients in the ZINCAiD Trial.

Biomolecules · 2025 · PMC12466942 · PMID 41008575

Europe PMCDOI
1
hedged sentence
0.0001
closest p · 0.0× alpha
0.0001
boldest claim

The sentences

highly significantp < 0.0001actually significant
Statistical findings reinforced this approach: A one-way ANOVA on mean percent change in Cp showed a strong group effect [F(2,36) = 50.42, p < 0.0001)], with post hoc Tukey HSD tests revealing no significant difference between Non-Responders and Placebo (mean difference = 0.25%, p = 0.998), but large, highly significant differences between Responders and Placebo (mean difference = 35.74%, p < 0.0001) and Responders and Non-Responders (mean difference = 35.49%, p < 0.0001).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.